NZ262929A - Molecules capable of binding to a hepatitis b escape mutant antigenic determinant, cell lines secreting them and their use - Google Patents

Molecules capable of binding to a hepatitis b escape mutant antigenic determinant, cell lines secreting them and their use

Info

Publication number
NZ262929A
NZ262929A NZ262929A NZ26292994A NZ262929A NZ 262929 A NZ262929 A NZ 262929A NZ 262929 A NZ262929 A NZ 262929A NZ 26292994 A NZ26292994 A NZ 26292994A NZ 262929 A NZ262929 A NZ 262929A
Authority
NZ
New Zealand
Prior art keywords
hepatitis
binding
cell lines
antigenic determinant
molecules capable
Prior art date
Application number
NZ262929A
Inventor
Jennifer Anne Waters
William Frederick Carman
Howard Christopher Thomas
Original Assignee
Imperial College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939306087A external-priority patent/GB9306087D0/en
Priority claimed from GB939311526A external-priority patent/GB9311526D0/en
Application filed by Imperial College filed Critical Imperial College
Publication of NZ262929A publication Critical patent/NZ262929A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ262929A 1993-03-24 1994-03-24 Molecules capable of binding to a hepatitis b escape mutant antigenic determinant, cell lines secreting them and their use NZ262929A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939306087A GB9306087D0 (en) 1993-03-24 1993-03-24 Specific binding molecules and their uses
GB939311526A GB9311526D0 (en) 1993-06-04 1993-06-04 Specific binding molecules and their uses

Publications (1)

Publication Number Publication Date
NZ262929A true NZ262929A (en) 1997-08-22

Family

ID=26302640

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ262929A NZ262929A (en) 1993-03-24 1994-03-24 Molecules capable of binding to a hepatitis b escape mutant antigenic determinant, cell lines secreting them and their use

Country Status (9)

Country Link
EP (1) EP0689605A1 (en)
JP (1) JPH08510635A (en)
CN (1) CN1121357A (en)
AU (1) AU681636B2 (en)
CA (1) CA2158866A1 (en)
NO (1) NO953749L (en)
NZ (1) NZ262929A (en)
PL (1) PL310699A1 (en)
WO (1) WO1994021812A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9608626D0 (en) * 1996-04-25 1996-07-03 Univ College Of London Hepatitis b monoclonal antibodies
EP0919568A1 (en) 1997-12-01 1999-06-02 Sorin Diagnostics S.r.l. Escape mutant of the surface antigen of hepatitis B virus
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
ES2488849T3 (en) * 2004-06-07 2014-08-29 Novartis Vaccines And Diagnostics, Inc. Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of use thereof
EP1806363B1 (en) * 2004-09-22 2013-09-04 Advanced Life Science Institute, Inc. METHOD OF DETECTING HEPATITIS B VIRUS s ANTIGEN
CN115598111A (en) * 2021-07-08 2023-01-13 南京大学（Cn） Specific hybridoma cell chemiluminescence screening method based on ortho-position induced immunoassay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007024D0 (en) * 1990-03-29 1990-05-30 Imperial College Novel vaccine
CA2067003A1 (en) * 1991-04-29 1992-10-30 Peter J. Kniskern Hbsag escape mutant vaccine

Also Published As

Publication number Publication date
WO1994021812A3 (en) 1994-11-10
AU6287094A (en) 1994-10-11
JPH08510635A (en) 1996-11-12
NO953749L (en) 1995-11-22
EP0689605A1 (en) 1996-01-03
WO1994021812A2 (en) 1994-09-29
AU681636B2 (en) 1997-09-04
CA2158866A1 (en) 1994-09-29
CN1121357A (en) 1996-04-24
PL310699A1 (en) 1995-12-27
NO953749D0 (en) 1995-09-22

Similar Documents

Publication Publication Date Title
EP0361229A3 (en) Polymer-bonded dyes, process for their preparation and their use
EP0486290A3 (en) A method and composition for increasing the accumulation of squalene and specific sterols in yeast
ZA851666B (en) Synthetic hepatitis b virus vaccine including both t cell and b cell determinants
ZA945720B (en) Electrode and preparation thereof
ZA948194B (en) Preparation of a modified polytetrafluoroethylene and use thereof
AU3259984A (en) Improved expression vector and use thereof
SG49733A1 (en) Reactive dyes preparation thereof and use thereof
IL99193A0 (en) Copolyimides,their preparation and their use
AU9179591A (en) Modified hepatocytes and uses therefor
GB9020730D0 (en) Manual sheet production and utilization apparatus
NZ262929A (en) Molecules capable of binding to a hepatitis b escape mutant antigenic determinant, cell lines secreting them and their use
GB9126918D0 (en) Members of specific binding pairs;methods of their making and using
EP0461499A3 (en) Use of efomycins a, e and g as antiinflammatory agents
OA09233A (en) Permanent waving process and compositions.
GB9102409D0 (en) Wrestler character figure
HK1007749A1 (en) Process for preparing a modified polytetrafluoroethylene and use thereof
DK426585A (en) PROCEDURE FOR EXPRESSING A FUNCTIONAL POLYPEPTIDE IN BACILLUS AND VECTOR FOR USING THE PROCEDURE
GB2280179B (en) Thermally stable iron oxide pigments,a process for their preparation and their use
EP0333653A3 (en) Reactive dyes, process for their preparation and their use
IL92281A0 (en) Polyimidesiloxanes,their preparation and use
GB8923812D0 (en) Reactive dyes and preparation and use thereof
GR890100860A (en) Composition based on trimebutyne and preparation process
EP0639189A4 (en) Pyridylpyrimidines, a method of preparing them, and their use in liquid-crystal mixtures.
EP0442086A3 (en) Graftcopolymers, their preparation and their use
GB2250531B (en) Improvements in and relating to closure members